Loading clinical trials...
Loading clinical trials...
Treatment of thromBocytopenia With EltRombopag or Intravenous Immune Globulin (IVIG) Before and DurING Invasive Procedures in Patients With Immune ThrombocytoPenia- BRIDGING ITP Study
Conditions
Interventions
Eltrombopag
IVIG infusion
Locations
10
Canada
University of Alberta Hospital
Edmonton, Alberta, Canada
Vancouver General Hospital
Vancouver, British Columbia, Canada
Hamilton Health Sciences
Hamilton, Ontario, Canada
London Health Sciences Center
London, Ontario, Canada
Ottawa Hospital
Ottawa, Ontario, Canada
Sunnybrook Hospital
Toronto, Ontario, Canada
Start Date
October 1, 2012
Primary Completion Date
June 1, 2019
Completion Date
August 1, 2019
Last Updated
September 9, 2020
NCT06722235
NCT04890041
NCT07426107
NCT07059910
NCT03866577
NCT00621894
Lead Sponsor
McMaster University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions